Population
Patients with morbid obesity seeking surgical or medical weight loss.
Design
Review
Authors
Loading...
Supports individualized risk-benefit discussions for bariatric candidates; leaves open need for prospective trials on anesthesia-specific outcomes.
Bariatric surgery, particularly Roux-en-Y gastric bypass, is an effective treatment for morbid obesity that produces significant weight loss and resolution of comorbidities such as Type II diabetes, though it carries specific surgical and anesthetic risks.
Ogunnaike et al. (2002) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: